NL7703011A - PROCESS FOR PREPARING 1-AZACARBOCYCLICAL 2-YLIDEEN DERIVATIVES OF GUANIDINE, PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION USING IT AND SUCH PREPARATION. - Google Patents

PROCESS FOR PREPARING 1-AZACARBOCYCLICAL 2-YLIDEEN DERIVATIVES OF GUANIDINE, PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION USING IT AND SUCH PREPARATION.

Info

Publication number
NL7703011A
NL7703011A NL7703011A NL7703011A NL7703011A NL 7703011 A NL7703011 A NL 7703011A NL 7703011 A NL7703011 A NL 7703011A NL 7703011 A NL7703011 A NL 7703011A NL 7703011 A NL7703011 A NL 7703011A
Authority
NL
Netherlands
Prior art keywords
preparing
preparation
ylideen
azacarbocyclical
guanidine
Prior art date
Application number
NL7703011A
Other languages
Dutch (nl)
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of NL7703011A publication Critical patent/NL7703011A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL7703011A 1976-03-19 1977-03-18 PROCESS FOR PREPARING 1-AZACARBOCYCLICAL 2-YLIDEEN DERIVATIVES OF GUANIDINE, PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION USING IT AND SUCH PREPARATION. NL7703011A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66838676A 1976-03-19 1976-03-19
US75258876A 1976-12-20 1976-12-20

Publications (1)

Publication Number Publication Date
NL7703011A true NL7703011A (en) 1977-09-21

Family

ID=27099888

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7703011A NL7703011A (en) 1976-03-19 1977-03-18 PROCESS FOR PREPARING 1-AZACARBOCYCLICAL 2-YLIDEEN DERIVATIVES OF GUANIDINE, PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION USING IT AND SUCH PREPARATION.

Country Status (21)

Country Link
JP (1) JPS52136168A (en)
AT (1) AT356669B (en)
AU (1) AU517804B2 (en)
CA (1) CA1100494A (en)
CH (4) CH635073A5 (en)
DD (1) DD130242A5 (en)
DE (1) DE2711757A1 (en)
DK (1) DK119477A (en)
ES (1) ES457010A1 (en)
FI (1) FI65243C (en)
FR (1) FR2361366A1 (en)
GB (1) GB1573532A (en)
GR (1) GR60780B (en)
IE (1) IE44792B1 (en)
IL (1) IL51694A (en)
NL (1) NL7703011A (en)
NO (1) NO148524C (en)
NZ (1) NZ183570A (en)
PH (1) PH16561A (en)
RO (1) RO71209A (en)
SE (1) SE423628B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000952A1 (en) * 1977-08-29 1979-03-07 McNeilab, Inc. Benzhydryl guanidine derivatives and pharmaceutical compositions
WO1995009619A2 (en) * 1993-10-04 1995-04-13 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA793186B (en) * 1978-07-06 1981-02-25 Duphar Int Res New urea and thiourea compounds, method of preparing the new compounds, as well as insecticidal compositions on the basis of these compounds
DE3061396D1 (en) * 1979-04-20 1983-01-27 Beecham Group Plc Oxazoline and thiazoline derivatives, processes for their preparation and pharmaceutical compositions containing them
JPS55160764A (en) * 1979-05-29 1980-12-13 Ciba Geigy Ag Guanidine* its manufacture and pharmaceutic medicine containing same
EP0028883A3 (en) 1979-11-10 1981-06-03 Beecham Group Plc Benzimidazoline derivatives, processes for their preparation and pharmaceutical compositions containing them
JPH06198992A (en) * 1992-11-30 1994-07-19 Shinko Seisakusho Co Ltd Cut-sheet conveying device
WO1994021621A1 (en) * 1993-03-23 1994-09-29 Astra Aktiebolag Guanidine derivatives useful in therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2205744A1 (en) * 1972-02-08 1973-08-09 Thomae Gmbh Dr K Guanidinylidene-subst cpds
CH578539A5 (en) * 1972-03-17 1976-08-13 Mcneilab Inc
US3803170A (en) * 1972-08-11 1974-04-09 Richardson Merrell Inc 2-((1-benzylcyclopentyl)imino)pyrrolidine

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000952A1 (en) * 1977-08-29 1979-03-07 McNeilab, Inc. Benzhydryl guanidine derivatives and pharmaceutical compositions
WO1995009619A2 (en) * 1993-10-04 1995-04-13 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
WO1995009619A3 (en) * 1993-10-04 1995-06-15 Wellcome Found Substituted urea and isothiourea derivatives as no synthase inhibitors
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors

Also Published As

Publication number Publication date
FI770864A (en) 1977-09-20
NO148524B (en) 1983-07-18
SE423628B (en) 1982-05-17
FI65243C (en) 1984-04-10
GR60780B (en) 1978-08-28
ES457010A1 (en) 1978-07-16
ATA190677A (en) 1979-10-15
JPS52136168A (en) 1977-11-14
AU2335177A (en) 1978-09-21
IL51694A (en) 1982-01-31
NO148524C (en) 1983-10-26
GB1573532A (en) 1980-08-28
CH636084A5 (en) 1983-05-13
JPS6327342B2 (en) 1988-06-02
AU517804B2 (en) 1981-08-27
RO71209A (en) 1981-11-04
IE44792L (en) 1977-09-19
FR2361366A1 (en) 1978-03-10
AT356669B (en) 1980-05-12
IE44792B1 (en) 1982-04-07
IL51694A0 (en) 1977-05-31
FI65243B (en) 1983-12-30
DE2711757A1 (en) 1977-09-22
CH634557A5 (en) 1983-02-15
CH635073A5 (en) 1983-03-15
SE7703114L (en) 1977-09-20
DD130242A5 (en) 1978-03-15
PH16561A (en) 1983-11-18
DK119477A (en) 1977-09-20
NO770959L (en) 1977-09-20
CH632994A5 (en) 1982-11-15
CA1100494A (en) 1981-05-05
NZ183570A (en) 1979-06-08
FR2361366B1 (en) 1984-03-02

Similar Documents

Publication Publication Date Title
NL7702954A (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS.
NL7514521A (en) PROCESS FOR PREPARING 3-AMINO-INDAZOLE CARBONIC ACID DERIVATIVES, PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION USING THEREOF AND SUCH PREPARATION.
NL7507441A (en) METHOD OF PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCEDURE FOR PREPARING SUITABLE MEDICINAL COMPOUNDS.
NL7706173A (en) PROCESS OF PREPARING NEW GUANIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS.
NL7710380A (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCEDURE FOR PREPARING SUITABLE ACTIVE COMPOUNDS.
NL7809404A (en) THIAZOLIC DERIVATIVES AND THIAZOLIC DERIVATIVES CONTAINING PHARMACEUTICAL PREPARATIONS AND METHODS FOR PREPARING ONE AND OTHER.
NL7703898A (en) PROCESS FOR PREPARING 2-SUBSTITUTED TRANS-HEXAHYDROPYRIDOINDOLS, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEREOF AND PREPARATIONS SO FORMED.
NL7706218A (en) PROCESS FOR PREPARING CLAUDOGENE INTERCEPTIVE NONAPEPTIDES, PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION USING THEREOF AND SUCH PREPARATION AS PREPARED.
NL7607011A (en) METHOD FOR PREPARING BICYCLOHEPEN COMPOUNDS, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION USING THEREOF AND AN SUCH PREPARATION.
NL7703011A (en) PROCESS FOR PREPARING 1-AZACARBOCYCLICAL 2-YLIDEEN DERIVATIVES OF GUANIDINE, PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION USING IT AND SUCH PREPARATION.
NL187478C (en) METHOD FOR PREPARING AMIDOXIM DERIVATIVES, AND METHOD FOR PREPARING A MEDICINAL PRODUCT
NL7704542A (en) PROCEDURE FOR PREPARING ISOTHIAZOLOPYRIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND.
NL7612937A (en) THIENAMYCINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS AND THE PROCESS FOR PREPARING THEM.
NL7704599A (en) METHOD FOR PREPARING A CEPHALOSPORIN SALT, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AND FORMED PHARMACEUTICAL PREPARATION.
NL7706888A (en) METHOD OF PREPARING A PHARMACEUTICAL PREPARATION.
NL7705406A (en) PROCESS FOR PREPARING 9- (2-O-ACYL- (BETA) -D- -ARABINOFURANOSYL) ADENINO COMPOUNDS, PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION USING THEREOF AND AN SUCHED PREPARATION.
NL7612941A (en) THIENAMYCINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS AND THE PROCESS FOR PREPARING THEM.
NL7705404A (en) METHOD FOR PREPARING 9- (3-O-ACYL- (BETA) -D- -ARABINOFURANOSYL) ADENINO COMPOUNDS AND 9- (2,3-DI-O-ACYL- (BETA) -D-ARABINOFURANOSYL) ADENINO COMPOUNDS, PROCESS OF PREPARING A PHARMACEUTICAL PREPARATION WITH USE THEREOF AND AN SUCHED PHARMACEUTICAL PREPARATION.
NL7707849A (en) METHOD OF PREPARING A PHARMACEUTICAL PREPARATION.
NL7606668A (en) OMEGA-AMINOALKOXYBENZENE DERIVATIVES AND PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING THEM.
NL7706619A (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
NL181408B (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTI-ALLERGY EFFECT, AND METHOD FOR PREPARING USE THEREOF 5-SUBSTITUTED 1H-TETRAZOLE DERIVATIVES.
NL7708807A (en) METHOD OF PREPARING A PHARMACEUTICAL PREPARATION.
NL7612939A (en) THIENAMYCINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS AND THE PROCESS FOR PREPARING THEM.
NL7612942A (en) THIENAMYCINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS AND THE PROCESS FOR PREPARING THEM.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed